UnitedHealth Group Inc. shared on Tuesday that its revenue in the third trimester of fiscal 2024 amounted to $100.8 billion, jumping 9% year over year.

In the three months ending September 30, on an annual basis, net earnings attributable to the company's common shareholders saw a 3.4% rise, climbing to $6 billion, while diluted earnings per share (EPS) rose 4.3% to $6.51. The business sees its full-year 2024 EPS at between $15.50 and $15.75.

"Our continued growth, which positions us well for the coming years, is rooted in the innovative products and responsive service of our people that are embraced each day across the full range of health care participants," CEO Andrew Witty commented.

UnitedHealth's stock fell 2.20% in the premarket following the release of the report.